Literature DB >> 4169964

Pathogenesis of the glomerulonephritis of NZB/W mice.

P H Lambert, F J Dixon.   

Abstract

The development of glomerulonephritis in NZB/W mice is closely related to the formation of antinuclear, particularly anti-DNA, antibodies. The developing inflammatory glomerular lesions are characterized by the deposition of gammaG- and beta(1C)-globulins plus DNA and possibly other nuclear antigens, presumably as complexes, in a granular to lumpy pattern along the capillary walls and in the mesangia. Elution studies revealed the gammaG-globulin in the glomeruli to be largely gammaG(2A)-type antibody to soluble nuclear antigens. Enhancement of the antinuclear antibody response by active immunization of young NZB/W mice with DNA-methylated BSA hastens the development and increases the severity of the glomerulonephritis. Similarly, injections of soluble DNA into NZB/W mice with circulating anti-DNA antibodies but with as yet little nephritis causes rapid progression of nephritis.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4169964      PMCID: PMC2138462          DOI: 10.1084/jem.127.3.507

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Nephrotoxic serum nephritis in complement intact and deficient mice.

Authors:  E R Unanue; M R Mardiney; F J Dixon
Journal:  J Immunol       Date:  1967-03       Impact factor: 5.422

2.  The development of renal lesions in NZB-NZW mice immunohistological studies.

Authors:  A R McGiven; J D Hicks
Journal:  Br J Exp Pathol       Date:  1967-06

3.  Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice.

Authors:  M B Oldstone; F J Dixon
Journal:  Science       Date:  1967-12-01       Impact factor: 47.728

4.  Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus.

Authors:  E M Tan
Journal:  J Lab Clin Med       Date:  1967-11

5.  An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus.

Authors:  E M Tan
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

6.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

Authors:  E M Tan; P H Schur; R I Carr; H G Kunkel
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

7.  Sodium transport and specific antiserum.

Authors:  G Terres; J X Loughran
Journal:  Nature       Date:  1967-08-12       Impact factor: 49.962

8.  Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis.

Authors:  C Krishnan; M H Kaplan
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

9.  Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice.

Authors:  R C Mellors; C Y Huang
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  207 in total

1.  Independent appearance of anti-thymocyte and anti-RNA antibodies in NZB/NZW F1 mice.

Authors:  R Goldblum; R Pillarisetty; N Talal
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

2.  Increased survival times of New Zealand hybrid mice immunosuppressed by graft-versus-host reactions.

Authors:  D H Lehman; C B Wilson; F J Dixon
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

3.  Acceleration of autoimmunity in NZB/NZW F1 mice by graft-versus-host disease.

Authors:  R Goldblum; R Pillarisetty; M J Dauphinee; N Talal
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

4.  Immunoglobulin and complement deposits in the lungs of New Zealand Black/White mice.

Authors:  D M Geddes; A J Leathem
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-07-26

5.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Authors:  H Heremans; A Billiau; A Colombatti; J Hilgers; P de Somer
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

6.  Improved survival in murine lupus as the result of selenium supplementation.

Authors:  J R O'Dell; J P McGivern; H D Kay; L W Klassen
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

7.  Suppression of development of anti-nuclear antibody and glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: possible involvement of superoxide anion as a progressive effector.

Authors:  T Hayashi; Y Noguchi; Y Kameyama
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

8.  Karyotypic, virologic, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity.

Authors:  R A Lerner; F Jensen; S J Kennel; F J Dixon; G Des Roches; U Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

9.  Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect.

Authors:  K H Sun; W T Liu; C Y Tsai; S J Tang; S H Han; C L Yu
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

10.  Human autoantibody recognition of DNA.

Authors:  S M Barbas; H J Ditzel; E M Salonen; W P Yang; G J Silverman; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.